首页 > 最新文献

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru最新文献

英文 中文
Vanek’s tumor: a rare differential diagnosis of colonic submucosal lesions Vanek肿瘤:结肠粘膜下病变的罕见鉴别诊断
Q4 Medicine Pub Date : 2023-09-30 DOI: 10.47892/rgp.2023.433.1534
Diego Berrospi-Castillo, Elsy Sotomayor-Trelles, Harold Benites Goñi
Gastrointestinal submucosal lesions represent a diagnostic challenge, including benign or malignant lesions, so they are identified more accurately by histopathological study accompanied by immunohistochemistry. This is a case of a 21-year-old man with a bleeding submucosal lesion in the cecum. The patient underwent a right colectomy. Microscopic finding was compatible with Vanek's tumor.
胃肠道粘膜下病变是一种诊断挑战,包括良性或恶性病变,因此通过组织病理学研究结合免疫组织化学更准确地识别它们。这是一个21岁的男性病例,在盲肠粘膜下病变出血。病人接受了右结肠切除术。显微镜下的发现与瓦内克的肿瘤相符。
{"title":"Vanek’s tumor: a rare differential diagnosis of colonic submucosal lesions","authors":"Diego Berrospi-Castillo, Elsy Sotomayor-Trelles, Harold Benites Goñi","doi":"10.47892/rgp.2023.433.1534","DOIUrl":"https://doi.org/10.47892/rgp.2023.433.1534","url":null,"abstract":"Gastrointestinal submucosal lesions represent a diagnostic challenge, including benign or malignant lesions, so they are identified more accurately by histopathological study accompanied by immunohistochemistry. This is a case of a 21-year-old man with a bleeding submucosal lesion in the cecum. The patient underwent a right colectomy. Microscopic finding was compatible with Vanek's tumor.","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135039841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Curar a veces, aliviar a menudo, consolar siempre 有时治愈,经常缓解,总是安慰
Q4 Medicine Pub Date : 2023-09-30 DOI: 10.47892/rgp.2023.433.1615
Hugo Guillermo Cedrón-Cheng
-
-
{"title":"Curar a veces, aliviar a menudo, consolar siempre","authors":"Hugo Guillermo Cedrón-Cheng","doi":"10.47892/rgp.2023.433.1615","DOIUrl":"https://doi.org/10.47892/rgp.2023.433.1615","url":null,"abstract":"-","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135039048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tromboembolia pulmonar masiva en un paciente con enfermedad de Crohn y tuberculosis latente tratada con ustekinumab 乌斯特克inumab治疗的克罗恩病和潜伏结核病患者的大量肺血栓栓塞
Q4 Medicine Pub Date : 2023-09-30 DOI: 10.47892/rgp.2023.433.1550
Siomara Aransuzú Chávez-Sánchez, Hugo Cedrón-Cheng
La enfermedad inflamatoria intestinal (EII) es un espectro de enfermedades crónicas inmunomediadas que afectan tanto el tracto gastrointestinal, como otros sistemas extraintestinales, comportándose como una enfermedad sistémica. Los fenómenos tromboembólicos son una complicación frecuente en la EII, como consecuencia de los estados de hipercoagulabilidad que se asocian con la actividad de la enfermedad, y su aparición tiene un impacto negativo tanto en el pronóstico como en la sobrevida de los pacientes. Debido a ello, el control de la actividad inflamatoria de la EII es uno de los pilares en el control de los eventos tromboembólicos. Los medicamentos biológicos se asocian al control rápido del cuadro inflamatorio, sin embargo, siempre se discute el tema de seguridad para la reactivación de infecciones latentes, en particular tuberculosis. Presentamos el caso de un paciente de 37 años que debutó con trombosis venosa profunda en el miembro inferior izquierdo y posteriormente con tromboembolismo pulmonar masivo. Luego de investigar la etiología y ampliar la historia clínica se le diagnosticó Enfermedad de Crohn (EC). Al realizar los estudios previos al uso de biológicos, las pruebas de PPD y quantiferon resultaron positivas, luego de la discusión del caso se decidió iniciar tratamiento con ustekinumab.
炎症性肠病(ibd)是一系列影响胃肠道和其他肠外系统的慢性免疫介导疾病,表现为全身性疾病。血栓栓塞现象是ibd常见的并发症,是与疾病活动相关的高凝状态的结果,其发生对预后和患者生存都有负面影响。因此,控制ibd的炎症活动是控制血栓栓塞事件的支柱之一。生物药物与炎症的快速控制有关,然而,对潜伏感染,特别是肺结核的再激活的安全性一直在讨论。在我们的研究中,我们发现了一种新的治疗方法,在这种方法中,患者的肺栓塞被认为是一种严重的疾病。在调查了病因和详细的临床病史后,他被诊断为克罗恩病(EC)。在使用生物制剂之前的研究中,PPD和quantiferon检测呈阳性,在讨论病例后,决定开始使用ustekinumab治疗。
{"title":"Tromboembolia pulmonar masiva en un paciente con enfermedad de Crohn y tuberculosis latente tratada con ustekinumab","authors":"Siomara Aransuzú Chávez-Sánchez, Hugo Cedrón-Cheng","doi":"10.47892/rgp.2023.433.1550","DOIUrl":"https://doi.org/10.47892/rgp.2023.433.1550","url":null,"abstract":"La enfermedad inflamatoria intestinal (EII) es un espectro de enfermedades crónicas inmunomediadas que afectan tanto el tracto gastrointestinal, como otros sistemas extraintestinales, comportándose como una enfermedad sistémica. Los fenómenos tromboembólicos son una complicación frecuente en la EII, como consecuencia de los estados de hipercoagulabilidad que se asocian con la actividad de la enfermedad, y su aparición tiene un impacto negativo tanto en el pronóstico como en la sobrevida de los pacientes. Debido a ello, el control de la actividad inflamatoria de la EII es uno de los pilares en el control de los eventos tromboembólicos. Los medicamentos biológicos se asocian al control rápido del cuadro inflamatorio, sin embargo, siempre se discute el tema de seguridad para la reactivación de infecciones latentes, en particular tuberculosis. Presentamos el caso de un paciente de 37 años que debutó con trombosis venosa profunda en el miembro inferior izquierdo y posteriormente con tromboembolismo pulmonar masivo. Luego de investigar la etiología y ampliar la historia clínica se le diagnosticó Enfermedad de Crohn (EC). Al realizar los estudios previos al uso de biológicos, las pruebas de PPD y quantiferon resultaron positivas, luego de la discusión del caso se decidió iniciar tratamiento con ustekinumab.","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135039835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical characteristics of early-onset gastric cancer. A study in a Colombian population 早发性胃癌的临床特点。一项针对哥伦比亚人口的研究
Q4 Medicine Pub Date : 2023-09-30 DOI: 10.47892/rgp.2023.433.1485
Marta Juliana Mantilla, Juan José Chaves, Miguel Ochoa-Vera, Ferney Africano, Rafael Parra-Medina, German Tovar-Fierro
Gastric cancer is a multifactorial disease with important genetic and environmental factors. It is the fifth most common cancer in incidence, and the fourth cause of death secondary to cancer. The incidence of early-onset gastric cancer is increasing worldwide, but clinical information on these patients has not been well established. We analyzed the association between age and clinical, endoscopic, and histopathological characteristics of gastric cancer at the time of diagnosis in a Latin American population. A retrospective and descriptive cross-sectional study was carried out using the database of the Gastroenterology Service of the Clínica Foscal and Clínica Foscal Internacional in Bucaramanga, Colombia. Between January 2016 and December 2019, 259 de novo gastric cancer cases were diagnosed, of which 36 patients (13.9%) were 40 years old or younger. In patients with early-onset gastric, the prevalence of gastric cancer diagnosis was lower in men. A family history of gastric cancer or any other neoplasm was not associated with a higher prevalence of gastric neoplasms. In young patients, vomiting and ascites were more common, the preferred anatomical location was the body of the stomach, and the Borrmann IV classification and thediffuse-type histology were more likely. Our study showed an approximation of the characteristics of early-onset gastric cancer in a Latin American population, where we observed that early-onset gastric cancer has different demographic, anatomical, and histological features than late-onset gastric cancer.
胃癌是一种多因素疾病,具有重要的遗传和环境因素。它是发病率第五大最常见的癌症,也是仅次于癌症的第四大死因。早发性胃癌的发病率在世界范围内呈上升趋势,但这些患者的临床资料尚未得到很好的确定。我们分析了拉丁美洲人群中年龄与诊断时胃癌的临床、内镜和组织病理学特征之间的关系。利用哥伦比亚布卡拉曼加的Clínica中心和Clínica国际中心的胃肠病学服务数据库进行了一项回顾性和描述性横断面研究。2016年1月至2019年12月,259例新发胃癌,其中36例(13.9%)年龄在40岁及以下。在早发性胃癌患者中,男性胃癌诊断率较低。胃癌或任何其他肿瘤的家族史与胃肿瘤的高患病率无关。年轻患者以呕吐、腹水多见,解剖位置以胃体为佳,以Borrmann IV型及弥漫性组织学多见。我们的研究显示了拉丁美洲人群中早发性胃癌特征的近似,我们观察到早发性胃癌与晚发性胃癌具有不同的人口统计学、解剖学和组织学特征。
{"title":"Clinical characteristics of early-onset gastric cancer. A study in a Colombian population","authors":"Marta Juliana Mantilla, Juan José Chaves, Miguel Ochoa-Vera, Ferney Africano, Rafael Parra-Medina, German Tovar-Fierro","doi":"10.47892/rgp.2023.433.1485","DOIUrl":"https://doi.org/10.47892/rgp.2023.433.1485","url":null,"abstract":"Gastric cancer is a multifactorial disease with important genetic and environmental factors. It is the fifth most common cancer in incidence, and the fourth cause of death secondary to cancer. The incidence of early-onset gastric cancer is increasing worldwide, but clinical information on these patients has not been well established. We analyzed the association between age and clinical, endoscopic, and histopathological characteristics of gastric cancer at the time of diagnosis in a Latin American population. A retrospective and descriptive cross-sectional study was carried out using the database of the Gastroenterology Service of the Clínica Foscal and Clínica Foscal Internacional in Bucaramanga, Colombia. Between January 2016 and December 2019, 259 de novo gastric cancer cases were diagnosed, of which 36 patients (13.9%) were 40 years old or younger. In patients with early-onset gastric, the prevalence of gastric cancer diagnosis was lower in men. A family history of gastric cancer or any other neoplasm was not associated with a higher prevalence of gastric neoplasms. In young patients, vomiting and ascites were more common, the preferred anatomical location was the body of the stomach, and the Borrmann IV classification and thediffuse-type histology were more likely. Our study showed an approximation of the characteristics of early-onset gastric cancer in a Latin American population, where we observed that early-onset gastric cancer has different demographic, anatomical, and histological features than late-onset gastric cancer.","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135039845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cáncer colorectal en el embarazo. Reportes de caso 妊娠期结直肠癌。病例报告
Q4 Medicine Pub Date : 2023-09-30 DOI: 10.47892/rgp.2023.433.1457
Silvia Ivonne Haro Sánchez, Samy Liz Jave Cardich
El cáncer colorrectal (CCR) durante el embarazo es una neoplasia poco frecuente, con una incidencia entre el 0,07- 0,1% en la población. Para un diagnóstico preciso es necesaria una alta sospecha y con ello realizar pruebas diagnósticas oportunas. Cuando no se tiene sospecha ni se busca el diagnóstico, el pronóstico suele ser malo, ya que muchas veces se halla en estado avanzado. Presentamos los casos de dos gestantes de 27 y 31 años, diagnosticadas de adenocarcinoma colorrectales medianamente diferenciados a las 29 y 30 semanas de gestación, respectivamente. Debido a la importancia de realizar un diagnóstico oportuno para mejorar la sobrevida de las pacientes, se realizó una búsqueda de información en la literatura en relación con el diagnóstico, manejo y pronóstico de esta patología.
妊娠期结直肠癌(crc)是一种罕见的肿瘤,在人群中发病率在0.07 - 0.1%之间。准确的诊断需要高怀疑和及时的诊断测试。当没有怀疑或寻求诊断时,预后通常很差,因为它通常处于晚期。在我们的研究中,我们发现了两种不同类型的结直肠腺癌,分别在妊娠29周和30周诊断为中等分化的结直肠腺癌。由于及时诊断对提高患者生存率的重要性,我们检索了有关该病诊断、治疗和预后的文献信息。
{"title":"Cáncer colorectal en el embarazo. Reportes de caso","authors":"Silvia Ivonne Haro Sánchez, Samy Liz Jave Cardich","doi":"10.47892/rgp.2023.433.1457","DOIUrl":"https://doi.org/10.47892/rgp.2023.433.1457","url":null,"abstract":"El cáncer colorrectal (CCR) durante el embarazo es una neoplasia poco frecuente, con una incidencia entre el 0,07- 0,1% en la población. Para un diagnóstico preciso es necesaria una alta sospecha y con ello realizar pruebas diagnósticas oportunas. Cuando no se tiene sospecha ni se busca el diagnóstico, el pronóstico suele ser malo, ya que muchas veces se halla en estado avanzado. Presentamos los casos de dos gestantes de 27 y 31 años, diagnosticadas de adenocarcinoma colorrectales medianamente diferenciados a las 29 y 30 semanas de gestación, respectivamente. Debido a la importancia de realizar un diagnóstico oportuno para mejorar la sobrevida de las pacientes, se realizó una búsqueda de información en la literatura en relación con el diagnóstico, manejo y pronóstico de esta patología.","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135039846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Asociación entre la vitamina D y las enfermedades inflamatorias intestinales 维生素D与炎症性肠病的关系
Q4 Medicine Pub Date : 2023-09-30 DOI: 10.47892/rgp.2023.433.1561
Alina Baz-López, Manuel Barreiro-de-Acosta
La vitamina D es una hormona conocida desde larga fecha, por sus efectos sobre la salud ósea y la regulación del metabolismo del fósforo y calcio. Desde el descubrimiento de receptores para esta molécula en un gran número de células del organismo, se ha abierto el campo para el estudio de sus efectos sobre el sistema inmune. Sus relaciones con las células del sistema inmune, genes y microbiota hace que el interés sea grande en relación con enfermedades inmunomediadas. Muchos datos indican que esta vitamina tiene efectos preventivos, moduladores y controladores de los efectos adversos de las Enfermedades Inflamatorias Intestinales (EII) en la salud ósea, aunque es difícil demostrar la causalidad de forma taxativa. En esta revisión intentamos resumir la situación actual y los temas de controversia en este interesante campo, centrándonos en las enfermedades inflamatorias intestinales.
维生素D是一种众所周知的激素,因为它对骨骼健康和调节磷和钙的代谢有影响。自从在人体大量细胞中发现这种分子的受体以来,研究其对免疫系统影响的领域就打开了。它们与免疫系统细胞、基因和微生物群的关系使人们对免疫介导的疾病非常感兴趣。许多数据表明,这种维生素具有预防、调节和控制炎症性肠病(ibd)对骨骼健康的不良影响的作用,尽管很难全面证明因果关系。在这篇综述中,我们试图总结这一有趣领域的现状和争议话题,重点关注炎症性肠病。
{"title":"Asociación entre la vitamina D y las enfermedades inflamatorias intestinales","authors":"Alina Baz-López, Manuel Barreiro-de-Acosta","doi":"10.47892/rgp.2023.433.1561","DOIUrl":"https://doi.org/10.47892/rgp.2023.433.1561","url":null,"abstract":"La vitamina D es una hormona conocida desde larga fecha, por sus efectos sobre la salud ósea y la regulación del metabolismo del fósforo y calcio. Desde el descubrimiento de receptores para esta molécula en un gran número de células del organismo, se ha abierto el campo para el estudio de sus efectos sobre el sistema inmune. Sus relaciones con las células del sistema inmune, genes y microbiota hace que el interés sea grande en relación con enfermedades inmunomediadas. Muchos datos indican que esta vitamina tiene efectos preventivos, moduladores y controladores de los efectos adversos de las Enfermedades Inflamatorias Intestinales (EII) en la salud ósea, aunque es difícil demostrar la causalidad de forma taxativa. En esta revisión intentamos resumir la situación actual y los temas de controversia en este interesante campo, centrándonos en las enfermedades inflamatorias intestinales.","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135039833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cáncer colorrectal post-colonoscopia: Evaluación de una cohorte en sus características clínicas, colonoscópicas, sobrevida y sus causas según la Organización Mundial de Endoscopia 结肠镜后结直肠癌:根据世界内窥镜组织对其临床、结肠镜特征、生存和病因的队列评估
Q4 Medicine Pub Date : 2023-09-30 DOI: 10.47892/rgp.2023.433.1517
Rodrigo Castaño-Llano, Diego Caycedo-Medina, Juan Darío Puerta, Juan Ricardo Jaramillo, Luis Palacios, Mauricio Rodríguez, Sandra Molina, Camilo Vásquez, Santiago Salazar, Juan Esteban Puerta, Isabella Cadavid
Cáncer colorrectal post-colonoscopia (CCRP) es el tumor que aparece posterior a una colonoscopia normal antes de cumplirse el tiempo establecido para seguimiento endoscópico. Origen multifactorial, refleja la calidad de la colonoscopia y las diferentes biologías tumorales entre los cánceres colorrectales detectados (CCRD) y el CCRP. Nuestro objetivo es describir las características del CCRP en nuestro medio, identificar factores de riesgo, discriminar sus causas según la Organización Mundial de Endoscopia (OME) y determinar el efecto en la sobrevida del paciente. El estudio se realizó en pacientes con cáncer-colorrectal (CCR) atendidos en consulta de gastro-oncología de dos instituciones en Medellín-Colombia, entre enero de 2012 y diciembre de 2021 que se habían sometido a una colonoscopia en los 6 a 36 meses anteriores a la colonoscopia en la que se diagnosticó el CCR. 919 pacientes durante 10 años por CCR, 68 casos de CCRP (6,9%), se encontró que se presenta con más frecuencia en pacientes mayores (74 vs. 66 años; p=0,03), con antecedentes de pólipos adenomatosos (36,8% vs. 20,1%; p=0,01) y en colon derecho (57,4% vs. 40,6%; p=0,006), con una tendencia en pacientes con diverticulosis (41,2% vs. 31,3%; p=0,05) y diabetes (25% vs. 14%; p=0,06); menor sobrevida a 5 y 10 años (58%-55,2% vs. 67%-63%; p<0,001). Según la OME, los CCRP se presentaron en 61,3% por lesiones omitidas en colonoscopias inadecuadas, 29% colonoscopias adecuadas y 9,7% resecciones incompletas de adenomas. En conclusión, la tasa de CCRP fue de 6,9%, con mayor propensión en pacientes de mayores, antecedente de resección de pólipos, y en colon derecho. Acorde a la OME, las lesiones omitidas más frecuentemente se relacionaron con colonoscopias inadecuadas. Los pacientes con CCRP tienen menor sobrevida.
结肠镜后结直肠癌(crp)是在正常结肠镜检查后出现的肿瘤,在内窥镜监测的时间完成之前。多因素起源,反映了结肠镜检查的质量和检测到的结直肠癌(crd)和crp的不同肿瘤生物学。我们的目标是描述我们环境中CCRP的特征,识别危险因素,根据世界内窥镜组织(OME)区分其原因,并确定对患者生存的影响。进行cáncer-colorrectal (CCR)接受治疗患者在Medellín-Colombia gastro-oncología查询两个机构,2012年1月至12月续约后,使一个colonoscopia在6至36个月前colonoscopia确诊CCR。919例10年crc患者,68例crp(6.9%),发现老年患者(74岁vs. 66岁;有腺瘤性息肉病史(36.8% vs. 20.1%;p= 0.01)和右结肠(57.4% vs. 40.6%;p= 0.006),憩室病患者有倾向(41.2% vs. 31.3%;p= 0.05)和糖尿病(25% vs. 14%;p = 0.06);5年和10年生存率较低(58%- 55.2% vs. 67%-63%;p< 0.001)。根据OME, 61.3%的crp是由于不充分的结肠镜检查遗漏的病变,29%是适当的结肠镜检查,9.7%是腺瘤不完全切除。在一项随机对照试验中,年龄较大的患者、既往息肉切除的患者和右结肠患者的pcrc患病率为6.9%。根据OME,遗漏的病变最常与不充分的结肠镜检查有关。CCRP患者的生存率较低。
{"title":"Cáncer colorrectal post-colonoscopia: Evaluación de una cohorte en sus características clínicas, colonoscópicas, sobrevida y sus causas según la Organización Mundial de Endoscopia","authors":"Rodrigo Castaño-Llano, Diego Caycedo-Medina, Juan Darío Puerta, Juan Ricardo Jaramillo, Luis Palacios, Mauricio Rodríguez, Sandra Molina, Camilo Vásquez, Santiago Salazar, Juan Esteban Puerta, Isabella Cadavid","doi":"10.47892/rgp.2023.433.1517","DOIUrl":"https://doi.org/10.47892/rgp.2023.433.1517","url":null,"abstract":"Cáncer colorrectal post-colonoscopia (CCRP) es el tumor que aparece posterior a una colonoscopia normal antes de cumplirse el tiempo establecido para seguimiento endoscópico. Origen multifactorial, refleja la calidad de la colonoscopia y las diferentes biologías tumorales entre los cánceres colorrectales detectados (CCRD) y el CCRP. Nuestro objetivo es describir las características del CCRP en nuestro medio, identificar factores de riesgo, discriminar sus causas según la Organización Mundial de Endoscopia (OME) y determinar el efecto en la sobrevida del paciente. El estudio se realizó en pacientes con cáncer-colorrectal (CCR) atendidos en consulta de gastro-oncología de dos instituciones en Medellín-Colombia, entre enero de 2012 y diciembre de 2021 que se habían sometido a una colonoscopia en los 6 a 36 meses anteriores a la colonoscopia en la que se diagnosticó el CCR. 919 pacientes durante 10 años por CCR, 68 casos de CCRP (6,9%), se encontró que se presenta con más frecuencia en pacientes mayores (74 vs. 66 años; p=0,03), con antecedentes de pólipos adenomatosos (36,8% vs. 20,1%; p=0,01) y en colon derecho (57,4% vs. 40,6%; p=0,006), con una tendencia en pacientes con diverticulosis (41,2% vs. 31,3%; p=0,05) y diabetes (25% vs. 14%; p=0,06); menor sobrevida a 5 y 10 años (58%-55,2% vs. 67%-63%; p<0,001). Según la OME, los CCRP se presentaron en 61,3% por lesiones omitidas en colonoscopias inadecuadas, 29% colonoscopias adecuadas y 9,7% resecciones incompletas de adenomas. En conclusión, la tasa de CCRP fue de 6,9%, con mayor propensión en pacientes de mayores, antecedente de resección de pólipos, y en colon derecho. Acorde a la OME, las lesiones omitidas más frecuentemente se relacionaron con colonoscopias inadecuadas. Los pacientes con CCRP tienen menor sobrevida.","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135039730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Massive pulmonary thromboembolism in a patient with Crohn's disease and latent tuberculosis treated with ustekinumab]. [使用ustekinumab治疗的克罗恩病和潜伏性肺结核患者出现大量肺血栓栓塞]。
Siomara Aransuzú Chávez-Sánchez, Hugo Cedrón-Cheng

Inflammatory bowel disease (IBD) is a spectrum of chronic immune-mediated diseases that affect the gastrointestinal tract and other extraintestinal systems, behaving as a systemic disease. Thromboembolic phenomena are a frequent complication in IBD, because of hypercoagulability states associated with disease activity, and their presence has a negative impact on prognosis and patient survival. Due to this, the control of the inflammatory activity of IBD is one of the pillars in the control of thromboembolic events. Biological drugs are associated with rapid control of the inflammatory process, however, the security profile for the reactivation of latent infections, particularly tuberculosis, is always discussed. We present the case of a 37-year-old patient who presented with deep vein thrombosis in the left lower limb and later with massive pulmonary thromboembolism. During his evaluation, he was diagnosed with Crohn's disease (CD). When carrying out the studies prior to the use of biologics, PPD and quantiferon tests were positive. After discussing the case, we decided to start treatment with ustekinumab.

炎症性肠病(IBD)是一系列影响胃肠道和其他肠外系统的慢性免疫介导疾病,表现为系统性疾病。血栓栓塞现象是IBD的常见并发症,因为高凝状态与疾病活动有关,其存在对预后和患者生存有负面影响。因此,控制IBD的炎症活性是控制血栓栓塞事件的支柱之一。生物药物与炎症过程的快速控制有关,然而,潜伏感染,特别是结核病的再激活的安全性一直在讨论中。我们报告了一例37岁的患者,他出现左下肢深静脉血栓形成,后来出现大量肺血栓栓塞。在评估期间,他被诊断为克罗恩病(CD)。在使用生物制剂之前进行研究时,PPD和quantiferon测试呈阳性。在讨论了这个病例后,我们决定开始使用ustekinumab进行治疗。
{"title":"[Massive pulmonary thromboembolism in a patient with Crohn's disease and latent tuberculosis treated with ustekinumab].","authors":"Siomara Aransuzú Chávez-Sánchez,&nbsp;Hugo Cedrón-Cheng","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Inflammatory bowel disease (IBD) is a spectrum of chronic immune-mediated diseases that affect the gastrointestinal tract and other extraintestinal systems, behaving as a systemic disease. Thromboembolic phenomena are a frequent complication in IBD, because of hypercoagulability states associated with disease activity, and their presence has a negative impact on prognosis and patient survival. Due to this, the control of the inflammatory activity of IBD is one of the pillars in the control of thromboembolic events. Biological drugs are associated with rapid control of the inflammatory process, however, the security profile for the reactivation of latent infections, particularly tuberculosis, is always discussed. We present the case of a 37-year-old patient who presented with deep vein thrombosis in the left lower limb and later with massive pulmonary thromboembolism. During his evaluation, he was diagnosed with Crohn's disease (CD). When carrying out the studies prior to the use of biologics, PPD and quantiferon tests were positive. After discussing the case, we decided to start treatment with ustekinumab.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"61565574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Start of enteral nutrition after an endoscopic gastrostomy, is it necessary to wait?] [内镜胃造口术后开始肠内营养,是否需要等待?]
William Otero-Regino, Hernando Marulanda-Fernández, Gilberto Jaramillo-Trujillo, Lina Otero-Parra, Julián Parga-Bermúdez, Felipe Vera-Polanía, Juan Antonio Trejos-Naranjo, Elder Otero Ramos

Traditionally, the initiation of enteral nutrition after a percutaneous endoscopic gastrostomy (PEG) is performed between 12 and 24 hours. Different research suggests that early initiation might be a safe option. Our aim was to determine whether starting enteral nutrition 4 hours after performing PEG is a safe practice in terms of risk of intolerance, complications, or death, compared to starting it at 12 hours. We carried out a prospective, randomized, multicenter study in third and fourth level institutions in Bogotá and Cundinamarca, between June 2020 and May 2022, 117 patients were included who were randomized into 2 groups, group A with early nutrition initiation (4 hours), and standard group B (12 hours). The most frequent mechanism of dysphagia was cerebrovascular disease (43%), followed by complications of COVID19 infection (26%). There were no statistically significant differences between the groups evaluated regarding the percentage of intolerance to nutrition, RR = 0.93 (CI 0.30-2.90), there were also no differences in terms of postoperative complications, (RR) = 0.34 (CI 0.09-1.16), and no differences were found in mortality between the evaluated groups, (RR) = 1.12 (CI 0.59-2.15). In conclusion, early initiation of nutrition through the gastrostomy, 4 hours after performing the PEG, is a safe behavior that is not related to greater intolerance to nutrition, complications, or death, compared to later initiation.

传统上,经皮内镜胃造瘘术(PEG)后的肠内营养开始时间为12至24小时。不同的研究表明,早期启动可能是一个安全的选择。我们的目的是确定在进行PEG后4小时开始肠内营养与在12小时开始肠外营养相比,在不耐受、并发症或死亡风险方面是否是一种安全的做法。2020年6月至2022年5月,我们在波哥大和昆迪纳马卡的三级和四级机构进行了一项前瞻性、随机、多中心研究,纳入117名患者,他们被随机分为两组,a组早期营养启动(4小时)和标准B组(12小时)。吞咽困难最常见的机制是脑血管疾病(43%),其次是COVID19感染的并发症(26%)。评估组之间对营养不耐受的百分比没有统计学上的显著差异,RR=0.93(CI 0.30-2.90),术后并发症也没有差异,(RR)=0.34(CI 0.09-1.16),评估组之间的死亡率也没有差异(RR)=1.12(CI 0.59-2.15)。总之,在进行PEG后4小时,通过胃造口术早期开始营养是一种安全的行为,与后期开始相比,这与更大的营养不耐受、并发症或死亡无关。
{"title":"[Start of enteral nutrition after an endoscopic gastrostomy, is it necessary to wait?]","authors":"William Otero-Regino,&nbsp;Hernando Marulanda-Fernández,&nbsp;Gilberto Jaramillo-Trujillo,&nbsp;Lina Otero-Parra,&nbsp;Julián Parga-Bermúdez,&nbsp;Felipe Vera-Polanía,&nbsp;Juan Antonio Trejos-Naranjo,&nbsp;Elder Otero Ramos","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Traditionally, the initiation of enteral nutrition after a percutaneous endoscopic gastrostomy (PEG) is performed between 12 and 24 hours. Different research suggests that early initiation might be a safe option. Our aim was to determine whether starting enteral nutrition 4 hours after performing PEG is a safe practice in terms of risk of intolerance, complications, or death, compared to starting it at 12 hours. We carried out a prospective, randomized, multicenter study in third and fourth level institutions in Bogotá and Cundinamarca, between June 2020 and May 2022, 117 patients were included who were randomized into 2 groups, group A with early nutrition initiation (4 hours), and standard group B (12 hours). The most frequent mechanism of dysphagia was cerebrovascular disease (43%), followed by complications of COVID19 infection (26%). There were no statistically significant differences between the groups evaluated regarding the percentage of intolerance to nutrition, RR = 0.93 (CI 0.30-2.90), there were also no differences in terms of postoperative complications, (RR) = 0.34 (CI 0.09-1.16), and no differences were found in mortality between the evaluated groups, (RR) = 1.12 (CI 0.59-2.15). In conclusion, early initiation of nutrition through the gastrostomy, 4 hours after performing the PEG, is a safe behavior that is not related to greater intolerance to nutrition, complications, or death, compared to later initiation.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"61565576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Endoscopic retrieval of migrated gastric band]. [胃束带移位的内窥镜检索]。
Juan Antonio Chirinos-Vega, Eduardo Vesco-Monteagudo, Patricia Valera-Luján, Aurelio Barboza-Beraún

This is a case report of a 47-year-old woman, carrier of an adjustable gastric band since 2018, that developed abdominal pain due to partial migration into the stomach. which was successfully removed endoscopically using Sohendra's lithotriptor.

这是一例47岁女性的病例报告,她自2018年以来一直携带可调节胃束带,由于部分迁移到胃中而出现腹痛。使用Sohendra的碎石机在内镜下成功取出。
{"title":"[Endoscopic retrieval of migrated gastric band].","authors":"Juan Antonio Chirinos-Vega, Eduardo Vesco-Monteagudo, Patricia Valera-Luján, Aurelio Barboza-Beraún","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This is a case report of a 47-year-old woman, carrier of an adjustable gastric band since 2018, that developed abdominal pain due to partial migration into the stomach. which was successfully removed endoscopically using Sohendra's lithotriptor.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"61565571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1